The Recall Desk
ModerateFDA (Devices)·Z-0534-2026·Announced 2025-11-26

Measles antibody tests recalled for being distributed without premarket clearance

Quest International is recalling ReQuest Measles IgG enzyme linked immunoassay kits because the in vitro diagnostic was distributed without premarket approval or clearance.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: Scored 2 because the record cites the absence of premarket clearance rather than any identified defect or reported harm.

Plain-English summary

The ReQuest Measles IgG, a Rubeola IgG enzyme linked immunosorbent assay, catalog number 01-190, from Quest International, is being recalled.

The recall follows distribution of the measles IgG in vitro diagnostic without premarket approval or clearance.

The recall covers lots L07024 and E03025, carrying DI 00850487007357. The product was distributed in Utah and Washington. The FDA has classified the action as Class II.

The enforcement record describes a missing premarket authorisation rather than an identified performance defect, and reports no injuries. Laboratories holding affected lots should follow the firm's instructions.

The recalled product

Product
Brand Name: ReQuest Measles IgG Product Name: Rubeola IgG Enzyme Linked Immunoabsorbant Assay Model/Catalog Number: 01-190 Software Version: N/A Product Description: Measles IgG tests, performed using ELISA (Enzyme-Linked Immunosorbent Assay) method, used to detect the presen
Manufacturer
Quest International, Inc.
Hazard
  • missing-clearance
  • regulatory-noncompliance

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot Code: DI# 00850487007357 Lots affected: L07024 and E03025

Distribution

Distribution scope not specified by the agency.